Revolution Medicines, Inc. Warrant Ownership | Who Owns Revolution Medicines, Inc. Warrant?
Revolution Medicines, Inc. Warrant Ownership Summary
Revolution Medicines, Inc. Warrant is owned by 0.10% institutional investors, 2.14% insiders, and 97.76% retail investors. Vanguard group is the largest institutional shareholder, holding 0.01% of RVMD shares. Vanguard Health Care Inv is the top mutual fund, with 3.28% of its assets in Revolution Medicines, Inc. Warrant shares.
RVMD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Revolution Medicines, Inc. Warrant | 0.10% | 2.14% | 97.76% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 14.38M | 0.01% | $558.02M |
| Wellington management group llp | 13.66M | 0.01% | $530.15M |
| Blackrock | 13.41M | 0.01% | $520.39M |
| Farallon capital management | 9.76M | 0.01% | $378.70M |
| Baker bros. advisors lp | 7.57M | 0.00% | $293.76M |
| Nextech invest | 6.30M | 0.00% | $244.38M |
| Bvf inc/il | 5.98M | 0.00% | $232.13M |
| Fmr | 5.63M | 0.00% | $218.34M |
| Price t rowe associates inc /md/ | 5.22M | 0.00% | $202.46M |
| Paradigm biocapital advisors lp | 5.26M | 0.00% | $204.11M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mass general brigham | 338.19K | 63.90% | $13.13M |
| Nextech invest | 6.30M | 41.11% | $244.38M |
| Casdin capital | 4.41M | 13.06% | $171.03M |
| Alphabet | 5.31M | 10.43% | $205.97M |
| Ah capital management | 2.75M | 9.10% | $106.67M |
| Boxer capital | 4.28M | 8.75% | $166.09M |
| Finepoint capital lp | 729.46K | 8.04% | $28.31M |
| Paradigm biocapital advisors lp | 5.26M | 7.81% | $204.11M |
| Bvf inc/il | 5.98M | 6.51% | $232.13M |
| Dafna capital management | 511.89K | 4.75% | $19.87M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | 5.26M | 7.81% | 2.34M |
| Farallon capital management | 9.76M | 1.79% | 2.25M |
| Norges bank | 1.85M | 0.01% | 1.85M |
| Fmr | 5.63M | 0.01% | 1.46M |
| Logos global management lp | 1.20M | 3.75% | 1.20M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Casdin capital | 4.41M | 13.06% | -1.21M |
| Wellington management group llp | 13.66M | 0.09% | -1.05M |
| Dimensional fund advisors lp | 390.58K | 0.00% | -940.68K |
| Marshall wace, llp | 816.05K | 0.04% | -719.88K |
| Perceptive advisors | - | - | -618.88K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.85M | 0.01% | 1.85M | $71.75M |
| Hood river capital management | 914.00K | 0.73% | 914.00K | $35.47M |
| Sofinnova investments | 455.10K | 0.92% | 455.10K | $17.66M |
| Nicholas investment partners, lp | 158.13K | 0.64% | 158.13K | $6.14M |
| Eam investors | 101.02K | 0.64% | 101.02K | $3.92M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -27.00 |
| Innealta capital | -38.00 |
| Weiss asset management lp | -226.00 |
| Elequin securities | -234.00 |
| Armstrong advisory group | -304.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 227 | 4.13% | 168,384,927 | 6.00% | - | 1101.87% | 125 | 20.19% | 57 | -13.64% |
| Mar 31, 2024 | 218 | 9.00% | 158,856,105 | -0.68% | - | 1024.97% | 104 | -25.18% | 66 | 88.57% |
| Dec 31, 2023 | 200 | 9.29% | 159,946,965 | 42.78% | - | 2105.90% | 139 | 31.13% | 35 | -10.26% |
| Sep 30, 2023 | 183 | 26.21% | 112,020,171 | -0.01% | - | 1474.78% | 106 | 47.22% | 39 | -4.88% |
| Jun 30, 2023 | 145 | -4.61% | 112,029,130 | 3.51% | - | 1580.31% | 72 | -32.71% | 41 | 36.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 5.48M | 3.28% | -1.06M |
| BB Biotech AG Ord | 4.86M | 2.91% | -147.94K |
| Vanguard Total Stock Mkt Idx Inv | 4.72M | 2.81% | -22.07K |
| iShares Russell 2000 ETF | 3.92M | 2.34% | -8.81K |
| Vanguard Small Cap Index | 3.77M | 2.25% | 7.40K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.35M | 1.40% | 363.77K |
| US Small-Cap Growth II Equity Comp | 2.13M | 1.27% | -6.49K |
| Vanguard Small Cap Growth Index Inv | 2.07M | 1.24% | -2.65K |
| SPDR® S&P Biotech ETF | 1.85M | 1.11% | 20.49K |
| T. Rowe Price New Horizons | 1.83M | 1.09% | -5.75K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 15, 2024 | Cislini Jeff | General Counsel | Sell | $140.81K |
| Nov 13, 2024 | Kelsey Stephen Michael | See Remarks | Sell | $805.81K |
| Nov 13, 2024 | Kelsey Stephen Michael | See Remarks | Sell | $171.69K |
| Nov 06, 2024 | Cislini Jeff | General Counsel | Sell | $360.00K |
| Nov 01, 2024 | GOLDSMITH MARK A | See Remarks | Sell | $275.10K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 17 |
| 2024 Q3 | - | 20 |
| 2024 Q2 | - | 19 |
| 2024 Q1 | - | 12 |
| 2023 Q4 | - | 15 |
RVMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools